Principal ® 2020 Platinum Equity Advisors, LLC. The blood glucose monitoring business will now operate as a standalone entity with a new corporate logo and brand identity. “We share an unwavering commitment to patient care and know there is tremendous opportunity for LifeScan to grow and evolve. The private investment firm proposed a binding offer to acquire LifeScan in March this year. You may unsubscribe at any time. All Rights Reserved. Our Newsletter is subject to our Privacy Notice.
Catching cancer: could a new blood test rewrite oncology?
E-mail Dan. There was a problem submitting your request.
All Rights Reserved. The business reaches nearly 20 million patients across more than 90 countries.
(function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? “We have worked closely with Johnson & Johnson to craft a divestiture solution for LifeScan that would create a global standalone business and set the stage for continued investment in growth and innovation.”.
Partner
By submitting your contact information, you acknowledge that you have read our Privacy Notice and that you consent to our processing of data in accordance with our Privacy Notice.
function OptanonWrapper() { } Platinum Equity Partner Jacob Kotzubei said that it will support LifeScan in improving the quality of life for people with diabetes. Last year, it generated approximately $1.5bn in net revenues. Johnson & Johnson sells LifeScan to Platinum Equity Allie Nawrat 15 June 2018 (Last Updated June 15th, 2018 15:32) Global pharmaceutical company Johnson & Johnson has accepted investment firm Plantinum Equity’s offer to acquire LifeScan, its blood glucose monitoring business, for approximately $2.1bn. +1 310.282.9202 Electronic Systems and Mechanical Devices for Medical Applications, Testing and Software Development for Medical Devices, Custom Touchscreen, Display Enhancement and Touch-Enabled Devices for Medical Applications, “LifeScan offers blood glucose monitoring products such as personal blood glucose meters, testing strips, lancets, point-of-care testing devices and integrated digital solutions under the OneTouch brand.”, 3 October 2018 (Last Updated October 3rd, 2018 11:17). LifeScan is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. Platinum Equity specializes in mergers, acquisitions and operations – a trademarked strategy it calls M&A&O.
If the offer is accepted, the transaction would be expected to close by the end of 2018, subject to the satisfaction of customary closing conditions. Visit GlobalData Store. +1 310.228.9514 Platinum Equity Submits Binding Offer to Acquire LifeScan from Johnson & Johnson » Johnson & Johnson Announces Acceptance of Binding Offer From Platinum Equity To Acquire LifeScan, Inc. » Platinum Equity Completes $2.1 Billion Acquisition of LifeScan from Johnson & Johnson » updated 10/18 +1 310.282.9202 (function (w, d, s, l, i) { w[l] = w[l] || []; w[l].push({ 'gtm.start': new Date().getTime(), event: 'gtm.js' }); var f = d.getElementsByTagName(s)[0], j = d.createElement(s), dl = l != 'dataLayer' ? E-mail Dan. With LifeScan’s talent and capabilities, our iconic OneTouch brand, and Platinum’s support, there’s no limit to what we can achieve.”. E-mail Mark, Dan Whelan LifeScan President Valerie Asbury would continue leading the business following the change in ownership. You have successfully subscribed to our list.
Principal Johnson & Johnson (J&J) has completed the sale of its subsidiary LifeScan to private investment firm Platinum Equity for a total consideration of around $2.1bn. We are strongly committed to protecting your privacy. J&J noted that following the divestiture it will cater to the needs of diabetes patients via other products, services and solutions in its Medical Device, Pharmaceuticals and Consumer businesses. LifeScan offers blood glucose monitoring products such as personal blood glucose meters, testing strips, lancets, point-of-care testing devices and integrated digital solutions under the OneTouch brand.
“LifeScan has been a leader in diabetes care for more than 30 years and has consistently developed and brought to market industry leading products,” said Platinum Equity Partner Jacob Kotzubei. “Once our offer is accepted we will work with the management team to ensure a seamless transition on behalf of patients, healthcare providers and the company’s employees around the world,” added Mr. Kotzubei. '&l=' + l : ''; j.async = true; j.src = 'https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f); })(window, document, 'script', 'dataLayer', 'GTM-TQKGM74'); “LifeScan is an innovative company that has been a leader in diabetes care for more than 30 years,” said Platinum Equity Partner Jacob Kotzubei.
J&J accepted the proposal in June, after consultation with relevant works councils and trade unions. Johnson & Johnson (J&J) has completed the sale of its subsidiary LifeScan to private investment firm Platinum Equity for a total consideration of around $2.1bn. LOS ANGELES (Oct 1, 2018) – Platinum Equity today announced that its acquisition of Lifescan from Johnson & Johnson (NYSE: JNJ) for approximately $2.1 billion has been completed, with the exception of certain non-U.S. jurisdictions that are each expected to close at a later date, subject to individual country regulatory requirements. You may unsubscribe at any time.
LifeScan is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. ExplORer Surgical: keeping device specialists close to the action, The relationship between FDI and international trade, FDA grants breakthrough designation to CartiHeal’s Agili-C implant, GE Healthcare secures FDA clearance for cardiovascular system, AI algorithm may enhance lung cancer detection, study finds, Avail Medsystems raises $100m for procedural telemedicine technology, Intersect ENT completes acquisition of Fiagon AG Medical Technologies, Medtronic to acquire medical device company Avenu Medical, Five must-read stories from the intersection of tech, business and politics, Biosense treats first patients with VARIPULSE catheter for AF, Roche to launch antigen test for Covid-19 patients, proposed a binding offer to acquire LifeScan, How ADGM makes doing business in Abu Dhabi easy, How one firm in Abu Dhabi is changing the data security game. Signing up for our Newsletter is subject to our Privacy Notice. We are strongly committed to protecting your privacy. LOS ANGELES (March 16, 2018) – Platinum Equity announced today that it has submitted a binding offer to acquire LifeScan, Inc. from Johnson & Johnson (NYSE: JNJ) in a transaction valued at approximately $2.1 billion. You have successfully subscribed to our list. The firm is currently investing from Platinum Equity Capital Partners IV, a $6.5 billion global buyout fund. NEW BRUNSWICK, N.J., March 16, 2018 – Johnson & Johnson (NYSE: JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. ® 2020 Platinum Equity Advisors, LLC. You may unsubscribe at any time. Headquartered in Chesterbrook, Pennsylvania and Zug, Switzerland, LifeScan serves approximately 20 million patients globally in more than 90 countries.
By clicking 'Send' you agree to receive communications from us. “This is an important investment for us in a business that serves millions of patients around the world. LifeScan president and CEO Val Asbury said: “We are excited for our future and what we can accomplish with the addition of Platinum Equity’s financial and operational resources. Latest report from
+1 310.228.9514 Founded in 1995 by Tom Gores, Platinum Equity is a global investment firm with $13 billion of assets under management and a portfolio of more than 30 operating companies that serve customers around the world. This is said to include innovation in various fields, including bariatric surgery, and drugs such as Invokana (canagliflozin) and Invokamet (canagliflozin/metformin HCl). The OneTouch portfolio includes personal blood glucose meters, testing strips, lancets, point of care testing systems and integrated digital solutions. LOS ANGELES (March 16, 2018) – Platinum Equity announced today that it has submitted a binding offer to acquire LifeScan, Inc. from Johnson & Johnson (NYSE: JNJ) in a transaction valued at approximately $2.1 billion. Our Newsletter is subject to our Privacy Notice. Browse over 50,000 other reports on our store. LifeScan offers blood glucose monitoring products such as personal blood glucose meters, testing strips, lancets, point-of-care testing devices and integrated digital solutions under the OneTouch brand.
.
Janssen Germany Address, Camping De La Pointe Mashteuiatsh, St Croix County Health Center New Richmond, Wi, Neutrogena Sunscreen Full Reach, Islamic Baby Girl Names From Quran Pdf, Boxlunch Arizona Mills, Teladoc Health, Asu Gammage, Johnson And Johnson Jobs Netherlands, 1 Liter To Cups, Caravan House For Sale, Gstt Training And Development, Alba Racing Exhaust, Anthony Albanese Family, Bon Secours Locations, Wilfried Zaha Wages Per Week, What's Wrong With This Picture Moon, Kelly Services Leave, Orange City, Fl Weather, Current State Of Virgin Islands, Role Of Bim In Construction, Islands Roblox Totems, No Background Check Apartments Tampa, Fl, Tsundere Anime, Lichfield Garrick Coronavirus, Clipsal Switches Bunnings, Cowgirl In The Sand Acoustic, Hellenic Medical Society Uk, Statistics About Eating At Home, Spanish Style Homes For Sale Kansas City, Theatre Royal Stratford East Contact, Ensemble Theatre Dress Code, Why Are Winx Club Dolls So Expensive, Kim Kyu Jong News, How Old Is Taro Yamada, Seattle Business Magazine Contact, Wired Uk Staff, Nicknames For Kelli, Spell Means, Utech Contact Number Soba, Interviews With Rachel Carson, Cooking Lesson Plans For Middle School, Medtronic News Layoffs, What's Wrong With This Picture Moon, Jamie T Lyrics Calm Down Dearest, Neutrogena Makeup Remover, Corey Seager Twitter, One Day At A Time Season 4 Episode 2, Eurotherm Drives 605 Manual, Choices:- The Royal Romance Book 2, Amazon Underground App, Youth Theatre, St Thomas Hospital Nashville History, For Sale By Owner Longwood, Fl 32750, Pros And Cons Of War Measures Act October Crisis, David Mitchell Son, Tactical Fighter Wing, Jessica Gahring Instagram, For The Roses Julie Garwood, Yandere Simulator Killing Senpai's Sister, Oisin Murphy Japan, The Hard Part The Blue Stones, Lnp E-newspaper, Victoria Hospital Number, Transgenic Plants Ppt, Winx Club Season 3 Episode 1 Full Episode English, The Mentor Network Internships,